Sign inCreate account

Report workspace tools

NCT05055427COMPLETEDanonymous

Efficacy of Shen Cao Gan Jiang Tang (Gan Cao Gan Jiang Tang With Ginseng) on Mild and Moderate COVID-19 Patients: A Multicenter, Prospective, Randomized Controlled Trial

Sponsor

Source record

University of Medicine and Pharmacy at Ho Chi Minh City

Phase

Source record

Phase 2/3

Modality

AI-normalized

small molecule

Target

AI-normalized

COVID-19

Indication / condition

AI-normalized

COVID-19 Respiratory Infection

Intervention

Source record

Shen Cao Gan Jiang Tang (Gan Cao Gan Jiang Tang with Ginseng)

Source & freshness

Source record

NCT ID

NCT05055427

Original source

ClinicalTrials.gov

Source last updated

May 31, 2023

Ingested at

May 23, 2026

Internal sync

Jun 05, 2026

Model version

trialsignal-ai-v1

Normalized confidence

88%

Validation status

validated

Open original registry record
View original source fields

NCT ID

NCT05055427

Title

Efficacy of Shen Cao Gan Jiang Tang (Gan Cao Gan Jiang Tang With Ginseng) on Mild and Moderate COVID-19 Patients: A Multicenter, Prospective, Randomized Controlled Trial

Sponsor

University of Medicine and Pharmacy at Ho Chi Minh City

Status

COMPLETED

Phase

Phase 2/3

Condition raw

COVID-19 Respiratory Infection

Condition normalized

COVID-19 Respiratory Infection

Modality raw

COVID-19 Respiratory Infection

Modality normalized

small molecule

Target raw

COVID-19

Target normalized

COVID-19

Interventions

Shen Cao Gan Jiang Tang (Gan Cao Gan Jiang Tang with Ginseng)

Public preview

Source record

This clinical trial evaluates the efficacy of Shen Cao Gan Jiang Tang, a traditional herbal formula, in treating mild and moderate COVID-19 patients. Conducted by the University of Medicine and Pharmacy at Ho Chi Minh City, the study aims to assess its impact on symptom duration, severity, and progression to severe disease compared to standard care.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections
Patent/IP landscape with verified records when available
Board-ready PDF export with source provenance
Save to folders and synthesize multiple assets in premium workspace
Create account
Sign in

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

Efficacy of Shen Cao Gan Jiang Tang (Gan Cao Gan Jiang Tang With Ginseng) on Mild and Moderate COVID-19 Patients: A Multicenter, Prospective, Randomized Controlled Trial

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 13, 2026

NCT ID

NCT05055427

Status

COMPLETED

Phase

Phase 2/3

Sponsor

University of Medicine and Pharmacy at Ho Chi Minh City

Executive brief

Investment-Ready Snapshot

This clinical trial evaluates the efficacy of Shen Cao Gan Jiang Tang, a traditional herbal formula, in treating mild and moderate COVID-19 patients. Conducted by the University of Medicine and Pharmacy at Ho Chi Minh City, the study aims to assess its impact on symptom duration, severity, and progression to severe disease compared to standard care.

Source & freshness

Provenance

SourceClinicalTrials.gov
Source updatedMay 31, 2023
Internal syncJun 05, 2026
Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT05055427

Indication

COVID-19 Respiratory Infection

Modality

small molecule

Target

COVID-19

Intervention

Shen Cao Gan Jiang Tang (Gan Cao Gan Jiang Tang with Ginseng)

Source record

Protocol Description

Detailed source ingestion pending.

Source record

Outcome Measures

Detailed source ingestion pending.

Source record

Eligibility

Detailed source ingestion pending.

AI analysis

Known Results And Readout Context

Detailed source ingestion pending.

IP intelligence

Patent And IP Landscape

Detailed source ingestion pending.

Source record

Contacts

Detailed source ingestion pending.